Fecal tests also result in a 42% reduction in deaths from left colon and rectal cancers, according to an Aug. 13 Medscape report.
Researchers compared 1,103 adults who had died of colorectal cancer between 2011 and 2017, with 9,608 matched, randomly selected people who were alive and free of the disease.
In a regression analysis, completing one or more FIT screenings was associated with a 33% lower risk for colorectal cancer death overall.
The benefits of FIT screening saw significant mortality reductions of 63% in non-Hispanic Asian, 42% in non-Hispanic Black, and 29% in non-Hispanic White individuals, according to the report.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.